ITFRF yields 5.03% · JNJ yields 2.14%● Live data
📍 ITFRF pulled ahead of the other in Year 1
Combined, ITFRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ITFRF + JNJ for your $10,000?
ITFOR Inc. provides support services for the implementation of information technology in Japan. It develops solutions comprising consulting, system configuration, customer specific solution development, operation, and management for network security. The company also offers financial solution systems, such as credit collection, loan assessment management, scoring, collecting, tele-marketing, and local governments systems; CTI systems that offer call-center productivity enhancements; consultation and installation of open platform for retail service customers; and e-commerce systems. In addition, it provides network systems, including corporate infrastructure network, backbone network consultation and design, IP services, edge solutions for telecom carriers, network security solutions, and personal information management; and professional and consultation services, as well as customer services. The company was formerly known as CJK Co. Ltd. and changed its name to ITFOR Inc. in 2000. ITFOR Inc. was founded in 1972 and is headquartered in Tokyo, Japan.
Full ITFRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.